Literature DB >> 23269642

The best-laid plans.

Raymond C Harris.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23269642      PMCID： PMC3625842          DOI： 10.1152/ajprenal.00693.2012

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  8 in total

Review 1.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

2.  Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

Authors:  Qing Qing Wu; Yanxia Wang; Martin Senitko; Colin Meyer; W Christian Wigley; Deborah A Ferguson; Eric Grossman; Jianlin Chen; Xin J Zhou; John Hartono; Pamela Winterberg; Bo Chen; Anapam Agarwal; Christopher Y Lu
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

3.  Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.

Authors:  Tomonaga Ichikawa; Jinqing Li; Colin J Meyer; Joseph S Janicki; Mark Hannink; Taixing Cui
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

4.  Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Authors:  Pablo E Pergola; Philip Raskin; Robert D Toto; Colin J Meyer; J Warren Huff; Eric B Grossman; Melissa Krauth; Stacey Ruiz; Paul Audhya; Heidi Christ-Schmidt; Janet Wittes; David G Warnock
Journal:  N Engl J Med       Date:  2011-06-24       Impact factor: 91.245

5.  Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.

Authors:  William O Osburn; Melinda S Yates; Patrick D Dolan; Sining Chen; Karen T Liby; Michael B Sporn; Keiko Taguchi; Masayuki Yamamoto; Thomas W Kensler
Journal:  Toxicol Sci       Date:  2008-04-15       Impact factor: 4.849

6.  Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects.

Authors:  Carla Zoja; Daniela Corna; Valeria Nava; Monica Locatelli; Mauro Abbate; Flavio Gaspari; Fabiola Carrara; Fabio Sangalli; Giuseppe Remuzzi; Ariela Benigni
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-07

Review 7.  New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress.

Authors:  Michael B Sporn; Karen T Liby; Mark M Yore; Liangfeng Fu; Justin M Lopchuk; Gordon W Gribble
Journal:  J Nat Prod       Date:  2011-02-10       Impact factor: 4.050

8.  Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy.

Authors:  Hongting Zheng; Samantha A Whitman; Wei Wu; Georg T Wondrak; Pak K Wong; Deyu Fang; Donna D Zhang
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461
  8 in total
  1 in total

1.  Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.

Authors:  Angelika F Winkel; Christian K Engel; Daniel Margerie; Aimo Kannt; Hauke Szillat; Heiner Glombik; Christopher Kallus; Sven Ruf; Stefan Güssregen; Jens Riedel; Andreas W Herling; Andreas von Knethen; Andreas Weigert; Bernhard Brüne; Dieter Schmoll
Journal:  J Biol Chem       Date:  2015-10-12       Impact factor: 5.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.